Your browser doesn't support javascript.
loading
Vedolizumab Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel Disease Patients Who Fail a Primary Biologic Agent.
Choi, Sujin; Kim, Eun Sil; Kwon, Yiyoung; Kim, Mi Jin; Choe, Yon Ho; Choe, Byung-Ho; Kang, Ben.
Afiliação
  • Choi S; Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Kim ES; Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kwon Y; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim MJ; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Choe YH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Choe BH; Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Kang B; Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Korea. benkang@knu.ac.kr.
J Korean Med Sci ; 37(37): e282, 2022 Sep 26.
Article em En | MEDLINE | ID: mdl-36163478
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article